Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion type Assertion NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_head.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion evidence source_evidence_literature NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion SIO_000772 21509760 NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion wasDerivedFrom befree-2016 NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.
- NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_assertion wasGeneratedBy ECO_0000203 NP888811.RAHQw6rJeEgOqj2X1fhQffc_PGa9hCXzPLVWsn28G6L58130_provenance.